Lv4
488 积分 2025-10-14 加入
Targeting IL-33 in COPD: mechanistic lessons from clinical trials and the path forward
18天前
已完结
Turning cold tumors hot: from molecular mechanisms to clinical applications
1个月前
已完结
Turning cold into hot: emerging strategies to fire up the tumor microenvironment
1个月前
已完结
中国炎症性肠病生物制剂治疗专家建议（试行）
1个月前
已完结
Oxidised IL-33 signals via RAGE/EGFR to drive a COPD-associated phenotype
1个月前
已关闭
Interleukin-33 antibody failed to demonstrate benefit in a phase II, double-blind, randomized, placebo-controlled study in adult patients with moderate-to-severe atopic dermatitis
1个月前
已完结
The global burden of COPD: epidemiology and effect of prevention strategies
2个月前
已完结
Treatment of chronic obstructive pulmonary disease: current pipeline and new opportunities
2个月前
已完结
皖公网安备34019202002308
